Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Melanoma. Found 38 abstracts

no pagination
Gibney GT, Hamid O, Lutzky J, Olszanski AJ, Mitchell TC, Gajewski TF, Chmielowski B, Hanks BA, Zhao Y, Newton RC, Maleski J, Leopold L, Weber JS. Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma. Journal for immunotherapy of cancer. 2019 Mar 20;7(1):80.   PMCID: PMC6425606
Ablain J, Xu M, Rothschild H, Jordan RC, Mito JK, Daniels BH, Bell CF, Joseph NM, Wu H, Bastian BC, Zon LI, Yeh I. Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma. Science (New York, NY). 2018 Nov 30;362(6418):1055-60.   PMCID: PMC6475924
Manley C, Olszanski A. Melanoma in the Bronchus. The New England journal of medicine. 2018 Nov 15;379(20):e36.
Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters M, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DS, Wang HJ, Elashoff DA, Elashoff RM. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. The New England journal of medicine. 2017 Jun 08;376(23):2211-22.   PMCID: PMC5548388
Lu H, Liu S, Zhang G, Bin W, Zhu Y, Frederick DT, Hu Y, Zhong W, Randell S, Sadek N, Zhang W, Chen G, Cheng C, Zeng J, Wu LW, Zhang J, Liu X, Xu W, Krepler C, Sproesser K, Xiao M, Miao B, Liu J, Song CD, Liu JY, Karakousis GC, Schuchter LM, Lu Y, Mills G, Cong Y, Chernoff J, Guo J, Boland GM, Sullivan RJ, Wei Z, Field J, Amaravadi RK, Flaherty KT, Herlyn M, Xu X, Guo W. PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas. Nature. 2017 Oct 05;550(7674):133-6.   PMCID: PMC5891348
Ndoye A, Budina-Kolomets A, Kugel CH, Webster MR, Kaur A, Behera R, Rebecca VW, Li L, Brafford PA, Liu Q, Gopal YN, Davies MA, Mills GB, Xu X, Wu H, Herlyn M, Nicastri MC, Winkler JD, Soengas MS, Amaravadi RK, Murphy ME, Weeraratna AT. ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma. Cancer Res. 2017 Nov;77(21):5873-85.   PMCID: PMC5718045
Ribas A, Dummer R, Puzanov I, VanderWalde A, Andtbacka RH, Michielin O, Olszanski AJ, Malvehy J, Cebon J, Fernandez E, Kirkwood JM, Gajewski TF, Chen L, Gorski KS, Anderson AA, Diede SJ, Lassman ME, Gansert J, Hodi FS, Long GV. Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy. Cell. 2017 Sep 07;170(6):1109-1119e10.
Sznol M, Postow MA, Davies MJ, Pavlick AC, Plimack ER, Shaheen M, Veloski C, Robert C. Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management. Cancer Treat Rev. 2017 Jul;58:70-6.
Sznol M, Postow MA, Davies MJ, Pavlick AC, Plimack ER, Shaheen M, Veloski C, Robert C. Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management. Cancer Treat Rev. 2017 Jul;58:70-6.   PMCID: Review
Zendejas B, Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S, Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Tyler D, Brady MS, Farley DR. Laparoscopic skill assessment of practicing surgeons prior to enrollment in a surgical trial of a new laparoscopic procedure. Surgical endoscopy. 2017 Aug;31(8):3313-9.   PMCID: PMC6201269
Zendejas B, Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S, Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Tyler D, Brady MS, Farley DR. Laparoscopic skill assessment of practicing surgeons prior to enrollment in a surgical trial of a new laparoscopic procedure. Surgical endoscopy. 2017 Aug;31(8):3313-9.
Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE, Daniels GA, DiMaio D, Ernstoff M, Fields RC, Fleming MD, Gonzalez R, Guild V, Halpern AC, Hodi FS, Joseph RW, Lange JR, Martini MC, Materin MA, Olszanski AJ, Ross MI, Salama AK, Skitzki J, Sosman J, Swetter SM, Tanabe KK, Torres-Roca JF, Trisal V, Urist MM, McMillian N, Engh A. Melanoma, version 2.2016 clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2016 Apr;14(4):450-73.
Czyz M, Toma M, Gajos-Michniewicz A, Majchrzak K, Hoser G, Szemraj J, Nieborowska-Skorska M, Cheng P, Gritsyuk D, Levesque M, Dummer R, Sliwinski T, Skorski T. PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas. Oncotarget. 2016 Nov 15;7(46):75551-60.   PMCID: PMC5342760
Hooper R, Zaidi MR, Soboloff J. The heterogeneity of store-operated calcium entry in melanoma. Science China Life sciences. 2016 Aug;59(8):764-9.   PMCID: PMC4991353
Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S, Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Allred JB, Suman VJ, Grotz TE, Zendejas B, Wayne JD, Tyler DS. Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial. Journal of the American College of Surgeons. 2016 Mar;222(3):253-60.   PMCID: PMC5012184
Zibelman M, Pollak N, Olszanski AJ. Autoimmune inner ear disease in a melanoma patient treated with pembrolizumab. Journal for immunotherapy of cancer. 2016 Feb;4:8.   PMCID: PMC4754989
Cheung M, Kadariya Y, Talarchek J, Pei J, Ohar JA, Kayaleh OR, Testa JR. Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interaction. Cancer letters. 2015 Dec 28;369(2):261-5.   PMCID: PMC4634709
Conde-Perez A, Gros G, Longvert C, Pedersen M, Petit V, Aktary Z, Viros A, Gesbert F, Delmas V, Rambow F, Bastian BC, Campbell AD, Colombo S, Puig I, Bellacosa A, Sansom O, Marais R, Van Kempen LC, Larue L. A caveolin-dependent and PI3K/AKT-independent role of PTEN in beta-catenin transcriptional activity. Nat Commun. 2015 Jan;6:8093.   PMCID: PMC4560817
Farma JM, Kulkarni N, Hsu C. Surgical management of primary and recurrent melanoma. Surg Oncol Clin N Am. 2015 Apr;24(2):239-47.
Hooper R, Zhang X, Webster M, Go C, Kedra J, Marchbank K, Gill DL, Weeraratna AT, Trebak M, Soboloff J. Novel Protein Kinase C-Mediated Control of Orai1 Function in Invasive Melanoma. Mol Cell Biol. 2015 Aug;35(16):2790-8.   PMCID: 4508319
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Melanoma

Melanoma pathology genetics metabolism Tumor Cell Line Skin Neoplasms Female surgery Mice Prognosis therapy drug effects diagnosis pharmacology Lymph Nodes Ipilimumab melanoma methods Neoplastic Gene Expression Regulation Mutation beta Catenin adverse effects Lymph Node Excision Membrane Proteins antagonists & inhibitors Melanocytes enzymology Proto-Oncogene Proteins B-raf Aged Physiological Feedback Groin dissection Western Blotting Calcium Signaling etiology Monoclonal Antibodies-Humanized Prospective Studies Clinical Competence Laparoscopy Lymphatic Metastasis Programmed Cell Death 1 Receptor Mitogen-Activated Protein Kinases Assessment Calcium drug therapy Antineoplastic Agents secondary Hypophysitis Clinical trial Neoplasms Signal Transduction Thyroiditis Male Minimally invasive Nivolumab Learning curve Immune-related adverse events Neoplasm Drug Resistance Videoscopic Inguinal Simulation diagnostic imaging education Postoperative Complications Ubiquitin Thiolesterase Enzyme Activation Wnt-5a Protein Intention to Treat Analysis Adult Protein Kinase C Survival Analysis Reproducibility of Results Middle Aged MAP Kinase Signaling System Intracellular Signaling Peptides and Proteins Epacadostat Lymphedema Transcriptional Activation JNK Mitogen-Activated Protein Kinases High-Volume Hospitals DNA Repair Local Neoplasm Recurrence Hearing loss PD-1 inhibitor Glycogen Synthase Kinase 3 mortality CTLA-4 Antigen Asbestos Immunohistochemistry Piperazines Medical Education-Continuing Proportional Hazards Models Dacarbazine Incidence Animal Disease Models deficiency Young Adult Gene-Environment Interaction Biological Models Randomized Controlled Trials as Topic Histones Sentinel Lymph Node Reverse Transcriptase Polymerase Chain Reaction Autophagy synthetic lethality Cancer predisposition Phosphatidylinositol 3-Kinases PARP1 inhibitor oncolytic viruses Experimental Melanoma Feasibility Studies Phosphorylation TOR Serine-Threonine Kinases Endoplasmic Reticulum Phthalazines Double-Stranded DNA Breaks Immune-related adverse events (irAEs) Calcium Channels Cultured Tumor Cells talimogene laherparepvec Bronchi Learning Curve United States Aminoquinolines Protein Kinase Inhibitors Local recurrence Cadherins Watchful Waiting Herpesviridae chemically induced CD274 Antigens Autoimmune inner ear disease (AIED) Biopsy technique Germ-Line Mutation Tumor Suppressor Proteins Bronchial Neoplasms Familial cancer Neoplasm Proteins tumor Groin Biopsy Immunotherapy ORAI1 Protein metastasis interferon gamma Drug Synergism Fluorescence Microscopy cytotixic Stromal Interaction Molecule 1 Synthetic Lethal Mutations chemistry
Last updated on Friday, January 03, 2020